Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03742154 · ClinicalTrials.gov registry record · Early Phase 1
Hollings Cancer Center Varenicline Sampling Study
A Early Phase 1 study of Smoking Cessation and Smoking, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT03742154 is a Early Phase 1 study of Smoking Cessation and Smoking that has completed, run by Medical University of South Carolina. The registered enrollment target is 99 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03742154, a Early Phase 1 study of Smoking Cessation and Smoking, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn what happens when people are given a free, 4-week, sample of varenicline, a smoking cessation medication. Investigators will look at quit attempts, changes in smoking, and attitude towards varenicline, in both smokers who want to quit and those who do not. Smoking use causes a number of deaths and diseases, including heart disease and cancer. All smokers are advised to quit. Varenicline (sometimes called Chantix), is a prescription medication approved by the US FDA. Many studies show that use of varenicline can help smokers quit smoking. Varenicline is a prescription medication, which usually means that people have to see a doctor to get it. This study examines a different way to deliver varenicline, delivered directly to participants for a few weeks, and without need to see a doctor. This method is called "varenicline sampling." The study is sponsored by the Hollings Cancer Center at the Medical University of South Carolina. The study is being done at the Medical University of South Carolina, but study recruitment is based state-wide, throughout South Carolina.
Conditions Studied
Interventions
- DRUG Varenicline 0.5 MG
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2018-12-03 |
| Est. Completion | 2020-04-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03742154
The ClinicalTrials.gov registry entry for NCT03742154 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (79% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Varenicline 0.5 MG is the first listed.
NCT03742154 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT03742154 about?
NCT03742154 is a clinical study titled "Hollings Cancer Center Varenicline Sampling Study". The purpose of this study is to learn what happens when people are given a free, 4-week, sample of varenicline, a smoking cessation medication. Investigators will look at quit attempts, changes in smoking, and attitude towards varenicline, in both smokers who want to quit and those who do not. Smok...
What is the current status of trial NCT03742154?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 99 participants. The study started on 2018-12-03. Estimated completion is 2020-04-06.
What conditions does trial NCT03742154 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Smoking, Cigarette, Smoking, Tobacco.
What interventions are being tested in trial NCT03742154?
The interventions under investigation include: Varenicline 0.5 MG (DRUG).
Who is sponsoring clinical trial NCT03742154?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03742154 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
End Nicotine Dependence Clinic
COMPLETED · Early Phase 1
-
Applying mHealth to Tobacco-related Health Disparities
COMPLETED · Early Phase 1
-
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
COMPLETED · Early Phase 1
-
Smoking by IV Pulsed Nicotine
COMPLETED · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.